Skip to main content

Brian D. Ford

Equibles does not estimate personal net worth.

About Brian D. Ford

Earlier roles on record: CFO at Grace Therapeutics, Inc. (GRCE) until January 5, 2024. Grace Therapeutics, Inc. reported in an 8-K filed January 8, 2024 that Brian D. Ford was terminated as interim-Chief Financial Officer, effective January 5, 2024. Grace Therapeutics, Inc. reported in an 8-K filed May 11, 2023 that Brian D. Ford was terminated as Chief Financial Officer, effective May 8, 2023.

“Concurrently with such appointment, the Board removed Brian Ford from the position of interim-Chief Financial Officer.”
Grace Therapeutics, Inc. Form 8-K, filed January 8, 2024 · Read the filing
“On May 8, 2023, the Company terminated the employment of Brian Ford, Chief Financial Officer; Pierre Lemieux, Chief Operating Officer (Canada); and George Kottayil, Chief Operating Officer (US).”
Grace Therapeutics, Inc. Form 8-K, filed May 11, 2023 · Read the filing

Affiliation history

Company network

Recent activity